Process Industries
Asahi Kasei Corp.
In the news
- Japan's battery startups take the world beyond lithium ion Aug 3, 2020
- Nippon Steel and Idemitsu tackle plastic waste in recycling push Jul 24, 2020
- Teijin to make medical gowns amid coronavirus shortage Apr 15, 2020
- Ventilator output ramps up as world braces for patient surge Mar 26, 2020
- Japan chemical makers to tap AI in joint materials project Feb 25, 2020 See more articles on Asahi Kasei Corp.
Business Summary
Asahi Kasei Corp. operates as a holding company which provides monitoring, planning, and strategic management to its subsidiaries and affiliates. Its operations are carried out through the following segments: Materials, Homes, Health Care, and Others. The Materials segment includes caustic soda, chlorine, acrylonitrile, styrene, methyl methacrylate, adipic acid, polyethylene, polystyrene, and other petrochemicals. The Homes segment includes "Long Life Home" products and also provides remodeling, real estate, and urban redevelopment. The Health Care segment includes pharmaceuticals and diagnostic reagents. The Others segment includes engineering, employment agency and temporary staffing services. The company was founded on May 21, 1931 and is headquartered in Tokyo, Japan.
Financial Highlights
| Mar 2020 | JPY | USD |
| Revenue | 2,151.64B | 19,789.65M |
| Gross Profit | 703,762M | 6,472.81M |
| Operating income | 177,264M | 1,630.37M |
| Income before tax | 155,934M | 1,434.19M |
| Net income | 103,931M | 955.90M |
| EBITDA | 295,568M | 2,718.47M |
| Diluted EPS | 74.84 | 0.68 |
| Dividends Per Share | 34 | 0.31 |
| Total Assets | 2,797.97B | 25,917.97M |
| Total liabilities | 1,414.51B | 13,102.82M |
| Total equity | 1,359.31B | 12,591.49M |
| Operating cash flow | 124,460M | 1,144.71M |
| Currency in JPY | Currency in USD |
Historical Data
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
| Revenue | 1,940.91B | 1,882.99B | 2,042.21B | 2,170.40B | 2,151.64B |
| Gross Profit | 606,344M | 606,826M | 672,802M | 715,748M | 703,762M |
| Operating income | 165,203M | 159,230M | 198,475M | 209,588M | 177,264M |
| Income before tax | 146,389M | 157,388M | 218,333M | 210,397M | 155,934M |
| Net income | 91,754M | 115,000M | 170,249M | 147,512M | 103,931M |
| EBITDA | 274,835M | 268,423M | 311,938M | 313,634M | 295,568M |
| Diluted EPS | 65.69 | 82.34 | 121.92 | 105.65 | 74.84 |
| Dividends Per Share | 20 | 24 | 34 | 34 | 34 |
| Total Assets | 2,211.72B | 2,254.50B | 2,307.15B | 2,575.20B | 2,797.97B |
| Total liabilities | 1,154.33B | 1,086.38B | 1,001.93B | 1,172.49B | 1,414.51B |
| Total equity | 1,041.90B | 1,151.34B | 1,287.38B | 1,381.48B | 1,359.31B |
| Operating cash flow | 216,218M | 168,965M | 249,891M | 212,062M | 124,460M |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
| Revenue | 16,162.93M | 17,388.81M | 18,426.16M | 19,571.75M | 19,789.65M |
| Gross Profit | 5,049.32M | 5,603.84M | 6,070.44M | 6,454.30M | 6,472.81M |
| Operating income | 1,375.72M | 1,470.43M | 1,790.76M | 1,889.97M | 1,630.37M |
| Income before tax | 1,219.05M | 1,453.42M | 1,969.93M | 1,897.26M | 1,434.19M |
| Net income | 764.07M | 1,061.98M | 1,536.09M | 1,330.19M | 955.90M |
| EBITDA | 2,288.68M | 2,478.79M | 2,814.50M | 2,828.21M | 2,718.47M |
| Diluted EPS | 0.54 | 0.76 | 1.10 | 0.95 | 0.68 |
| Dividends Per Share | 0.16 | 0.22 | 0.30 | 0.30 | 0.31 |
| Total Assets | 19,678.17M | 20,232.43M | 21,693.96M | 23,266.05M | 25,917.97M |
| Total liabilities | 10,270.29M | 9,749.48M | 9,421.12M | 10,593.05M | 13,102.82M |
| Total equity | 9,269.99M | 10,332.44M | 12,105.18M | 12,481.23M | 12,591.49M |
| Operating cash flow | 1,800.55M | 1,560.33M | 2,254.67M | 1,912.28M | 1,144.71M |
Valuation Measures
| Mar 2020 | |
| PER | 10.21 |
| ROA | 3.86% |
| ROE | 7.58% |
| Operating margin | 8.23% |
| Profit margin | 4.83% |
Key executives
- Executive President & Representative Director: Hideki Kobori
- Director, Head-Information Technology & Finance: Yutaka Shibata
- General Manager-Research & Development: Hiroshi Shirai
- Head-Risk, Compliance, Legal & General Affairs: Nobuyuki Kakizawa
- Director & Executive Vice President: Hiroshi Yoshida
Shareholders
- Nippon Life Insurance Co. (4.6%)
- Asset Management One Co., Ltd. (3.7%)
- Nomura Asset Management Co., Ltd. (3.4%)
- Sumitomo Mitsui Trust Asset Management Co., Ltd. (3.1%)
- Capital Research & Management Co. (World Investors) (2.9%)
- BlackRock Fund Advisors (2.6%)
- The Vanguard Group, Inc. (2.5%)
- Asahi Kasei Employee Stock Ownership Plan (2.3%)
- Capital Research & Management Co. (Global Investors) (2.1%)
- Sumitomo Mitsui Financial Group, Inc. (1.8%)
Contact Details
- Website:http://www.asahi-kasei.co.jp
- Address: Hibiya Mitsui Tower, 1-1-2 Yuraku-cho, Tokyo, 100-0006, Japan
- Phone: +81.3.6699.3000
Related Companies
- Asahi Kasei Pharma Denmark A/S
- Asahikasei Haus SSI Co. Ltd.
- Polypore KK
- Asahi-Schwebel Co. Ltd.
- Asahi Kasei Plastics America, Inc.
- Asahi Kasei Corporate Venture Capital
- Asahi Kasei Board Incentive Plan
- Asahi-Schewebel Co., Ltd.
- Asahi Tokyo Investment Trust Management Co., Ltd.
- Asahi Kasei Europe GmbH
- Asahi Kasei (China) Investment Co. Ltd.
- Kyokuyo Textile (Thailand) Co. Ltd.
- Asahi Kasei Synthetic Rubber Europe NV/SA
- Asahi Kasei Deutschland GmbH
- Asahi Kasei E-Materials Korea, Inc.
- Asahi Kasei Medical Trading (Korea) Co. Ltd.
- Asahi Kasei Tibbi Cihazlar Tic Ltd. Sti
- Asahi Kasei (Suzhou) Plastics Compound Co. Ltd.
- Asahi Kasei EMD Taiwan Corp.
- Asahikasei Plastics (Hong Kong) Co. Ltd.
- Asahi Kasei Fibers Italia SRL
- Asahikasei Plastics (America), Inc.
- Asahi Kasei POM (Zhangjiagang) Co. Ltd.
- ASAHI KASEI MICROZA (Hangzhou) Co. Ltd.
- Asahi Kasei Bioprocess Europe NV/SA
- Asahi Kasei Medical Trading Taiwan Co. Ltd.
- Asahi Kasei Microdevices Korea Corp.
- Asahi Kasei Microdevices (Shanghai) Co. Ltd.
- Asahi Kasei Fibers International (Shanghai) Co. Ltd.
- Asahi Kasei Electronics Materials Changshu Co. Ltd.
Competitors
- Chemours Co.
- Sumitomo Chemical Co., Ltd.
- Eternal Materials Co., Ltd.
- LG Chem Ltd.
- Celanese Corporation
- Trinseo SA
- Shen Ma Industry Co. Ltd. Class A
- NEXT SCIENCE Co.,Ltd.
- Everspin Technologies, Inc.
- HC SemiTek Corp. Class A
- Nephros, Inc.
- Shenzhen Capchem Technology Co., Ltd. Class A
- CytoSorbents Corporation
- Cirrus Logic, Inc.
- Fresenius Medical Care AG & Co. KGaA
- Green Seal Holding Ltd.
- Stryker Corporation
Copyright © 2020 FactSet Research Systems Inc. All rights reserved.
Last Updated on 5 Aug, 2020